2 Healthcare Stocks You Can Buy and Hold for the Next Decade
It is difficult to know accurately what the world will look like 10 years from now, but some predictions seem relatively safe. Here are just two examples. First, in a decade, equity markets will be up from their current levels.
Second, the need for lifesaving medicines won't have subsided 10 years from today. If these predictions hold, which seems very likely, it might be worth it for investors to add shares of top drugmakers to their portfolios. Let's consider two excellent candidates: Novo Nordisk (NYSE: NVO) and Incyte (NASDAQ: INCY).
Denmark-based Novo Nordisk delivered a strong performance last year. The company's net sales for 2021 came in at 140.8 billion Danish Kroner ($20.9 billion), 11% higher than the previous fiscal year. Among the drugmaker's top-performing products, its diabetes lineup continues to do well. Novo Nordisk has been one of the leaders in diabetes care for decades.
Source Fool.com
